GENEVA, Oct. 5 -- THE UNIVERSITY OF OSAKA filed a patent application (JP2026/012810) for “NUCLEAR MEDICINE THERAPEUTIC AGENT FOR THYROID CANCER”. With publication no. WO/2026/205501, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 51/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....